Camargo Pharmaceutical Services will acquire Paidion Research, a global pediatric clinical research organization (CRO) based in Durham, N.C.
"Half of all patients affected by a rare disease are children," said Camargo CEO, Dan Duffy. "Pediatric research is critical to success as we work to deliver a comprehensive solution to emerging biopharma companies with specialized needs. We are proud to partner with the Paidion team, who have earned their reputation as the leader in pediatric clinical research."
Established in 2013 by CEO Barry Mangum, PharmD, FCP, and COO Betsy Reid, Paidion is the only clinical research company in the United States solely dedicated to children. The Paidion team includes research executives with more than 30 years of experience in academia, global CROs and pharmaceutical companies.
Subscribe to our e-Newsletters
Stay up to date with the latest news, articles, and events. Plus, get special offers
from Pharmaceutical Outsourcing – all delivered right to your inbox! Sign up now!
"Our mission is to provide clinical research services that improve the health of children," Mangum said. "Together with Camargo, we can now deliver end-to-end pediatric drug development solutions to reach more patients faster."
"We are excited to partner with Camargo and help our Customers accelerate development, achieve better outcomes, and reach more patients in need," Reid said.